Concepedia

P. Geborek

PG

53

Publications

4.9K

Citations

35

H-Index

1988

Active since

Affiliations

Lund University(Current)

Spenshult Hospital

Karolinska Institutet

Skåne University Hospital

Uppsala University Hospital

P. Geborek is an author at Lund University specializing in medicine, rheumatology, and health sciences.

ORCID

Top concepts

Publications per year

1988–2017

53

Publications

53

Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas

P. Geborek · Annals of the Rheumatic Diseases · 2005 · 429 citations · Full text

Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists

Johan Askling, C. Michael Fored, L. Brandt et al. · Annals of the Rheumatic Diseases · 2007 · 334 citations · Full text

Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis

Meliha C Kapetanovic, Tore Saxne, Åke Sjöholm et al. · Lara D. Veeken · 2005 · 319 citations · Full text

Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial

Ronald van Vollenhoven, Sofia Ernestam, P. Geborek et al. · The Lancet · 2009 · 316 citations

, , +12

Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register

Johan Askling, Eva Baecklund, Fredrik Granath et al. · Annals of the Rheumatic Diseases · 2008 · 259 citations

Rows per page

1–5 of 53